Previous editions
Muy Global | Ed. 20 | Apr 2024
• Alliance between Invima and University of Antioquia: Looking to promote public production of medicines.
• Impact on maritime transportation: Disruptions in the Panama and Suez canals.
• Colombia and Japan join forces: Alliance for the study of a vaccine against Mpox.
• FDA approves Idorsia's Tryvio: Indicated for persistent hypertension.
Muy Global | Ed. 19 | Mar 2024
• ISO 9001:2015: We obtained certification.
• Cervical cancer: Prevention is key to protect yourself.
• Topical gene therapy for rare diseases: Krystal presents great success.
• Insulin shortage in the country: Minsalud clarifies situation.
• Dolutegravir: Requirements for its sale.
Muy Global | Ed. 18 | Ene 2024
• Blood test detected early stage Alzheimer's: New detection method.
• First subcutaneous injection of immunotherapy against cancer: European Commission approves Roche's Tecentriq SC.
• Studies to the Colombian health system: Recommendations of ANIF and AFIDRO.
• Risankizumab: lasting efficacy in psoriasis.
• Top 10 most anticipated launches: New drugs for 2024.
Subscribe
Keep informed of the most important news of the pharmaceutical industry